MAP1LC3A and hepatocellular carcinoma: Previous studies of LC3 expression in terms of clinical outcomes have reported controversial results.21, 22, 23 Our previous work showed that high LC3 levels in both the liver and tumor microenvironments are significantly correlated with decreased HCC recurrence and increased OS after surgical resection.